SCHEMBL5582032

SCHEMBL5582032

Fc1ccc(Cn2c(-c3ccc(F)cc3F)nc3ccccc32)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.56
GAA P10253 1/20 0.56
KMT2A Q03164 8/20 0.53
MEN1 O00255 6/20 0.52
KDM4E B2RXH2 3/20 0.52
HTT P42858 5/20 0.51
TSHR P16473 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
CYP3A4 P08684 1/20 0.51
LMNA P02545 4/20 0.50
MAPT P10636 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
NPY1R P25929 1/20 0.50
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13965209 0.83 CTSD (0.65) TP53GAAKMT2AMEN1KDM4E
SCHEMBL13835248 0.81 KMT2A (0.54) TP53GAAKMT2AMEN1KDM4E
SCHEMBL13834603 0.79 KMT2A (0.55) TP53GAAKMT2AMEN1KDM4E
SCHEMBL31551700 0.78 KDM4E (0.48) TP53KMT2AMEN1KDM4EHTT
SCHEMBL6298381 0.76 SMN1; SMN2 (0.49) TP53GAAKMT2AMEN1KDM4E
SCHEMBL27611222 0.75 SMN1; SMN2 (0.48) TP53GAAKMT2AMEN1KDM4E
SCHEMBL3868966 0.74 RECQL (0.53) KMT2AMEN1KDM4EHTTSMN1; SMN2
SCHEMBL13965210 0.73 KDM4E (0.52) TP53GAAKMT2AMEN1KDM4E
SCHEMBL27593044 0.73 RECQL (0.52) KMT2AMEN1KDM4EHTTSMN1; SMN2
SCHEMBL1482083 0.73 KMT2A (0.49) TP53GAAKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7193088-B2 Iridium complexes as light emitting materials and organic light emitting diode device CHI MEI OPTOELECTRONICS (TW) 2007-03-20 US disclosed
US-7193088-B2 Iridium complexes as light emitting materials and organic light emitting diode device CHI MEI OPTOELECTRONICS (TW) 2007-03-20 US disclosed
US-7193088-B2 Iridium complexes as light emitting materials and organic light emitting diode device CHI MEI OPTOELECTRONICS (TW) 2007-03-20 US disclosed
US-20050116626-A1 Iridium complexes as light emitting materials and organic light emitting diode device Innolux Corporation (TW) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050116626-A1 Iridium complexes as light emitting materials and organic light emitting diode device ORC3, CRY1, ITGA1 TP53 4524/4885GAA 4545/4885KMT2A 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.